Application of three-dimensional cell culture technology in screening anticancer drugs

Yaqian Sun1, Haiyang Ma2

  • 1Oncology laboratory, Faculty of Environment and Life, Beijing University of Technology, Beijing, 100124, China. 15064664062@163.com.

PubMed

Insights

Three-dimensional (3D) cell culture improves preclinical anticancer drug screening by better mimicking the in vivo tumor microenvironment. This advanced method enhances the prediction of drug activity and resistance compared to traditional 2D cell cultures.

Area of Science:

  • Pharmacology and Drug Discovery
  • Oncology Research
  • Biotechnology and Cell Culture

Background:

  • Current preclinical anticancer drug screening predominantly uses 2D cell cultures.
  • Traditional 2D cell culture inadequately simulates the in vivo tumor microenvironment and solid tumor characteristics.
  • This limitation results in poor prediction accuracy for anticancer drug activity and resistance.

Purpose of the Study:

  • To discuss common 3D cell culture techniques.
  • To emphasize the advantages of 3D cell culture in preclinical drug evaluation.
  • To highlight the application of 3D cell culture in assessing anti-tumor drug resistance.

Main Methods:

  • Review of established 3D cell culture methodologies.
  • Comparative analysis of 3D versus 2D cell culture models.
  • Focus on techniques relevant to simulating in vivo conditions.

Main Results:

  • 3D cell culture offers a more biologically relevant model than 2D culture.
  • It better reflects in vivo cellular states and tumor microenvironments.
  • 3D models demonstrate superior accuracy in predicting drug activity and resistance.

Conclusions:

  • 3D cell culture serves as an intermediate step between 2D culture and animal studies.
  • It enhances the predictive power for anticancer drug efficacy and resistance.
  • This approach provides valuable strategies for optimizing preclinical anti-tumor drug screening.

Related Concept Videos